US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist

3.6000
-0.0300-0.83%

Close Nov 1 16:00 ET

4.1680
+0.5680+15.78%

Post 19:52 ET

13.73MMarket Cap-534P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

30.22%-9.68M

7.07%-13.88M

-1,947.76%-14.94M

-283.87%-729.39K

93.05%-190.01K

49.69%-2.73M

-5.43M

Net income from continuing operations

26.21%-12.17M

-38.08%-16.5M

-317.49%-11.95M

47.47%-2.86M

-5.84%-5.45M

22.69%-5.15M

---6.66M

Operating gains losses

274.35%59.53K

-172.36%-34.14K

134.92%47.18K

0.00%20.09K

-24.40%20.09K

54.58%26.57K

--17.19K

Depreciation and amortization

0.00%11.41K

13.51%11.41K

--10.05K

--0

----

Other non cash items

----

2,277.98%989.5K

-42.36%41.61K

-93.56%72.19K

-34.84%1.12M

98.30%1.72M

--867.2K

Change In working capital

38.41%2.25M

151.38%1.63M

-255.24%-3.17M

-50.45%2.04M

516.48%4.12M

96.23%667.75K

--340.29K

-Change in receivables

--0

-61.73%-21.8K

-1,448.20%-13.48K

102.43%1K

-192.07%-41.1K

--44.64K

-Change in prepaid assets

-190.55%-632.13K

469.46%698.12K

-5,334.40%-188.95K

78.32%-3.48K

-317.26%-16.04K

138.78%7.38K

---19.03K

-Change in payables and accrued expense

199.69%2.93M

133.47%976.37K

-240.16%-2.92M

27.55%2.08M

132.60%1.63M

122.92%701.47K

--314.68K

-Change in other current liabilities

11.40%-42.24K

-22.51%-47.68K

-59.88%-38.92K

---24.34K

----

-Change in other working capital

----

--2.5M

----

Cash from discontinued investing activities

Operating cash flow

30.22%-9.68M

7.07%-13.88M

-1,947.76%-14.94M

-283.87%-729.39K

93.05%-190.01K

49.69%-2.73M

---5.43M

Investing cash flow

Cash flow from continuing investing activities

-39.56K

Net PPE purchase and sale

--0

---39.56K

--0

----

Cash from discontinued investing activities

Investing cash flow

--0

---39.56K

--0

----

Financing cash flow

Cash flow from continuing financing activities

-90.61%1.63M

-14.46%17.4M

3,939.12%20.34M

23.57%503.52K

-26.96%407.48K

-91.71%557.92K

6.73M

Net issuance payments of debt

97.83%1.63M

139.24%825.84K

-276.82%-2.1M

78.26%1.19M

19.67%667.69K

-83.83%557.92K

--3.45M

Net common stock issuance

--0

-36.65%9.22M

--14.55M

--0

----

--3.28M

Proceeds from stock option exercised by employees

--0

-6.83%7.35M

--7.89M

--0

----

Net other financing activities

----

-163.90%-686.7K

---260.21K

----

Cash from discontinued financing activities

Financing cash flow

-90.61%1.63M

-14.46%17.4M

3,939.12%20.34M

23.57%503.52K

-26.96%407.48K

-91.71%557.92K

--6.73M

Net cash flow

Beginning cash position

64.76%8.95M

5,695.69%5.43M

-57.46%93.71K

3,198.40%220.27K

-99.69%6.68K

147.28%2.18M

--882.77K

Current changes in cash

-328.89%-8.05M

-34.41%3.52M

2,474.10%5.36M

-203.86%-225.86K

110.00%217.47K

-268.05%-2.17M

--1.29M

Effect of exchange rate changes

--0

99.60%-100

-124.92%-24.74K

2,658.83%99.31K

-183.49%-3.88K

-123.04%-1.37K

--5.94K

End cash Position

-89.97%897.68K

64.76%8.95M

5,695.69%5.43M

-57.46%93.71K

3,198.40%220.27K

-99.69%6.68K

--2.18M

Free cash flow

30.22%-9.68M

7.32%-13.88M

-1,953.18%-14.98M

-283.87%-729.39K

93.05%-190.01K

49.69%-2.73M

---5.43M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	30.22%-9.68M	7.07%-13.88M	-1,947.76%-14.94M	-283.87%-729.39K	93.05%-190.01K	49.69%-2.73M	-5.43M
Net income from continuing operations	26.21%-12.17M	-38.08%-16.5M	-317.49%-11.95M	47.47%-2.86M	-5.84%-5.45M	22.69%-5.15M	---6.66M
Operating gains losses	274.35%59.53K	-172.36%-34.14K	134.92%47.18K	0.00%20.09K	-24.40%20.09K	54.58%26.57K	--17.19K
Depreciation and amortization	0.00%11.41K	13.51%11.41K	--10.05K	--0	--0	----	----
Other non cash items	----	2,277.98%989.5K	-42.36%41.61K	-93.56%72.19K	-34.84%1.12M	98.30%1.72M	--867.2K
Change In working capital	38.41%2.25M	151.38%1.63M	-255.24%-3.17M	-50.45%2.04M	516.48%4.12M	96.23%667.75K	--340.29K
-Change in receivables	--0	--0	-61.73%-21.8K	-1,448.20%-13.48K	102.43%1K	-192.07%-41.1K	--44.64K
-Change in prepaid assets	-190.55%-632.13K	469.46%698.12K	-5,334.40%-188.95K	78.32%-3.48K	-317.26%-16.04K	138.78%7.38K	---19.03K
-Change in payables and accrued expense	199.69%2.93M	133.47%976.37K	-240.16%-2.92M	27.55%2.08M	132.60%1.63M	122.92%701.47K	--314.68K
-Change in other current liabilities	11.40%-42.24K	-22.51%-47.68K	-59.88%-38.92K	---24.34K	----	----	----
-Change in other working capital	----	----	----	----	--2.5M	----	----
Cash from discontinued investing activities
Operating cash flow	30.22%-9.68M	7.07%-13.88M	-1,947.76%-14.94M	-283.87%-729.39K	93.05%-190.01K	49.69%-2.73M	---5.43M
Investing cash flow
Cash flow from continuing investing activities	0	0	-39.56K	0	0
Net PPE purchase and sale	--0	--0	---39.56K	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	--0	--0	---39.56K	--0	--0	----	----
Financing cash flow
Cash flow from continuing financing activities	-90.61%1.63M	-14.46%17.4M	3,939.12%20.34M	23.57%503.52K	-26.96%407.48K	-91.71%557.92K	6.73M
Net issuance payments of debt	97.83%1.63M	139.24%825.84K	-276.82%-2.1M	78.26%1.19M	19.67%667.69K	-83.83%557.92K	--3.45M
Net common stock issuance	--0	-36.65%9.22M	--14.55M	--0	--0	----	--3.28M
Proceeds from stock option exercised by employees	--0	-6.83%7.35M	--7.89M	--0	--0	----	----
Net other financing activities	----	----	----	-163.90%-686.7K	---260.21K	----	----
Cash from discontinued financing activities
Financing cash flow	-90.61%1.63M	-14.46%17.4M	3,939.12%20.34M	23.57%503.52K	-26.96%407.48K	-91.71%557.92K	--6.73M
Net cash flow
Beginning cash position	64.76%8.95M	5,695.69%5.43M	-57.46%93.71K	3,198.40%220.27K	-99.69%6.68K	147.28%2.18M	--882.77K
Current changes in cash	-328.89%-8.05M	-34.41%3.52M	2,474.10%5.36M	-203.86%-225.86K	110.00%217.47K	-268.05%-2.17M	--1.29M
Effect of exchange rate changes	--0	99.60%-100	-124.92%-24.74K	2,658.83%99.31K	-183.49%-3.88K	-123.04%-1.37K	--5.94K
End cash Position	-89.97%897.68K	64.76%8.95M	5,695.69%5.43M	-57.46%93.71K	3,198.40%220.27K	-99.69%6.68K	--2.18M
Free cash flow	30.22%-9.68M	7.32%-13.88M	-1,953.18%-14.98M	-283.87%-729.39K	93.05%-190.01K	49.69%-2.73M	---5.43M
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data